These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29083051)

  • 41. Lip abscess associated with isotretinoin treatment of acne vulgaris.
    Huoh KC; Chang KW
    JAMA Dermatol; 2013 Aug; 149(8):960-1. PubMed ID: 23760516
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus.
    Lee MC; Rios AM; Aten MF; Mejias A; Cavuoti D; McCracken GH; Hardy RD
    Pediatr Infect Dis J; 2004 Feb; 23(2):123-7. PubMed ID: 14872177
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical practice. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus.
    Daum RS
    N Engl J Med; 2007 Jul; 357(4):380-90. PubMed ID: 17652653
    [No Abstract]   [Full Text] [Related]  

  • 44. Septic Arthritis and Atopic Dermatitis: 2 Cases and a Review of the Recent Literature.
    Kusunoki T; Shimozono F; Maruki M; Futami T; Fujii T
    J Investig Allergol Clin Immunol; 2015; 25(3):225-7. PubMed ID: 26182693
    [No Abstract]   [Full Text] [Related]  

  • 45. Treatment of Recalcitrant Acrodermatitis Continua of Hallopeau With Brodalumab.
    Milani-Nejad N; Kaffenberger J
    J Drugs Dermatol; 2019 Oct; 18(10):1047. PubMed ID: 31603633
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Randomized controlled trial of trimethoprim-sulfamethoxazole for uncomplicated skin abscesses in patients at risk for community-associated methicillin-resistant Staphylococcus aureus infection.
    Schmitz GR; Bruner D; Pitotti R; Olderog C; Livengood T; Williams J; Huebner K; Lightfoot J; Ritz B; Bates C; Schmitz M; Mete M; Deye G
    Ann Emerg Med; 2010 Sep; 56(3):283-7. PubMed ID: 20346539
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Skin infection by community-acquired methicillin resistant Staphylococcus aureus with familial transmission].
    Balbuena Segura AI; Corrales Fernández MJ; Gea Velázquez de Castro MT
    Med Clin (Barc); 2016 Feb; 146(3):139-40. PubMed ID: 26228257
    [No Abstract]   [Full Text] [Related]  

  • 48. Severe myelosuppression and MRSA infection as the presentation of perinatal HIV infection.
    Rhee EJ; Linden C; Adler A; Burns J; Marcinak J
    Pediatr Infect Dis J; 2011 Aug; 30(8):727-8. PubMed ID: 21750452
    [No Abstract]   [Full Text] [Related]  

  • 49. A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis.
    Papp KA; Reich K; Paul C; Blauvelt A; Baran W; Bolduc C; Toth D; Langley RG; Cather J; Gottlieb AB; Thaçi D; Krueger JG; Russell CB; Milmont CE; Li J; Klekotka PA; Kricorian G; Nirula A
    Br J Dermatol; 2016 Aug; 175(2):273-86. PubMed ID: 26914406
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tildrakizumab (Ilumya) - another IL-23 antagonist for psoriasis.
    Med Lett Drugs Ther; 2019 Jan; 60(1563):4-6. PubMed ID: 30681661
    [No Abstract]   [Full Text] [Related]  

  • 51. [Soft tissue infection by probable community-acquired methicillin-resistant Staphylococcus aureus].
    Sopena Bert E; Cortiella Masdeu A; Qanneta R; Moltó Llarena E
    Rev Argent Microbiol; 2013; 45(1):61. PubMed ID: 23560792
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical pharmacology of the anti-IL-17 receptor antibody brodalumab (KHK4827) in Japanese normal healthy volunteers and Japanese subjects with moderate to severe psoriasis: a randomized, dose-escalation, placebo-controlled study.
    Osamu N; Hirotaka N; Koji S; Kenji T
    J Dermatol Sci; 2014 Sep; 75(3):201-4. PubMed ID: 24957501
    [No Abstract]   [Full Text] [Related]  

  • 53. Brodalumab versus ustekinumab in psoriasis.
    Fioranelli M; Roccia MG; Lotti T
    Dermatol Ther; 2016 Sep; 29(5):298. PubMed ID: 26627075
    [No Abstract]   [Full Text] [Related]  

  • 54. Eyelid Dermatitis as a Side Effect of Interleukin-17A Inhibitors in Psoriasis.
    Teraki Y; Takahashi A; Inoue Y; Takamura S
    Acta Derm Venereol; 2018 Apr; 98(4):456-457. PubMed ID: 29327064
    [No Abstract]   [Full Text] [Related]  

  • 55. Necrotizing pneumonia caused by Panton-Valentine leukocidin-producing methicillin-susceptible Staphylococcus aureus (MSSA).
    Catena V; Baiocchi M; Lentini P; Badolati L; Baccarin M; Del Monte DD; Rubini A
    Infez Med; 2012 Sep; 20(3):205-10. PubMed ID: 22992562
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatitis: a rare, but important, complication of infliximab therapy for psoriasis.
    Wahie S; Alexandroff A; Reynolds NJ
    Clin Exp Dermatol; 2006 May; 31(3):460-1. PubMed ID: 16681606
    [No Abstract]   [Full Text] [Related]  

  • 57. MRSA infection.
    Valand K; McLoughlin PM
    Br Dent J; 2009 Oct; 207(7):304. PubMed ID: 19816463
    [No Abstract]   [Full Text] [Related]  

  • 58. Management and outcome of adults with skin and soft tissue infection caused by methicillin-resistant Staphylococcus aureus in a tertiary hospital in central Taiwan.
    Teh SH; Chi CY; Lin PC; Ho CM; Chou CH; Tsai CT; Wang JH; Ho MW
    J Microbiol Immunol Infect; 2015 Oct; 48(5):497-503. PubMed ID: 25446039
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Coagulase-Negative Staphylococcus Skin and Soft Tissue Infections.
    Natsis NE; Cohen PR
    Am J Clin Dermatol; 2018 Oct; 19(5):671-677. PubMed ID: 29882122
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical manifestations and outcome of skin infections caused by the community-acquired methicillin-resistant Staphylococcus aureus clone ST80-IV.
    Del Giudice P; Bes M; Hubiche T; Roudière L; Blanc V; Lina G; Vandenesch F; Etienne J
    J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):164-9. PubMed ID: 20569290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.